MediFocus Inc. (MDFZF)

Oncology Corporate Profile

HQ Location

10240 Old Columbia Rd. Suite G
Columbia, SC 21046

Company Description

Medifocus, Inc. develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”).  The Company owns two technology platforms with approximately 100 issued and pending US and international patents.

Website: http://www.medifocusinc.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
APA-1000adaptive phased array (APA)Breast cancerIII

Source


http://www.medifocusinc.com

Recent News Headlines

Medifocus, Inc. Announces First Ever Quarterly Operating Profit and Significant Improvement in Operating Results for the Nine Months Ended December 31, 2016

3/16/2017 01:01 pm

[Accesswire] - COLUMBIA, MD / ACCESSWIRE / March 16, 2017 / Medifocus, Inc. (OTCQB: MDFZF and TSX-V: MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...

MEDIFOCUS INC. Financials

3/14/2017 05:00 pm

Medifocus, Inc. Announces Significant Improvement in Operating Results for the Six Months Ended September 30, 2016

12/19/2016 03:00 pm

[Accesswire] - COLUMBIA, MD / ACCESSWIRE / December 19, 2016 / Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...

Medifocus Inc. Announces Appointment of New Chief Executive Officer

10/3/2016 04:01 pm

[CNW Group] - Medifocus Inc. Announces Appointment of New Chief Executive Officer

Medifocus Inc. Announces Appointment of New Chief Executive Officer

10/3/2016 04:01 pm

[PR Newswire] - COLUMBIA, MD, Oct. 3, 2016 /PRNewswire/ - Medifocus, Inc. (OTCQX:MDFZF and TSXV:MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, today announced the appointment of William Jow, M.D. to the position of Chief Executive Officer, effective October 1, 2016, replacing Augustine Y. Cheung, Ph.D., the founder of the Company. "We thank Dr. Cheung for his service at Medifocus and wish Dr. Cheung the best in the next phase of his career." said Mr. Grant Walsh, Chairman of the Board of Directors.

Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016

9/14/2016 09:00 pm

[CNW Group] - Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016

Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016

9/14/2016 09:00 pm

[PR Newswire] - COLUMBIA, MD, Sept. 14, 2016 /PRNewswire/ - Medifocus, Inc. (OTCQX:MDFZF and TSXV:MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...

Medifocus, Inc. Signs Research & Development and Manufacturing Agreement for Its Patented Technology of Heat-Activated and Tumor Targeted Immunotherapy and Gene Therapy

1/13/2016 01:00 pm

[Marketwired] - Medifocus, Inc. , a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, and heat activated ...

Medifocus, Inc. Announces the Engagement of Tanaka Kapec Design Group, Inc. as Lead Designer of Next Generation of Prolieve(R) Thermodilatation System

1/11/2016 01:00 pm

[Marketwired] - Medifocus, Inc. a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, and Heat Activated Tumor ...

Medifocus, Inc. Announces Closing of First Tranche of Units Offering

12/14/2015 03:05 pm

[Marketwired] - Medifocus Inc. announces that it has completed the first tranche of its previously announced private placement. The Company issued 78.5 Units at a price of U.S. $10,000 per Unit for gross proceeds of U.S. ...

Medifocus, Inc. Announces Financial Results for the Six Months Ending September 30, 2015

12/7/2015 02:05 pm

[Marketwired] - Medifocus, Inc. reported its financial results for the second fiscal quarter ending September 30, 2015.

Medifocus, Inc. Obtains Two Newly Allowed Canadian Patents on the Prevention and Safety for the Treatment for Breast Cancer

12/1/2015 01:01 pm

[at noodls] - Medifocus Inc. Obtains Two Newly Allowed Canadian Patents on the Prevention and Safety for the Treatment for Breast Cancer COLUMBIA, Md. and Toronto, ON- December 5, 2014 - Medifocus, Inc. (OTCQX: MDFZF ...

Medifocus, Inc. Announces Exclusive Agreement With Major Academic Medical Center to License Technology to Develop Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy

10/29/2015 08:05 am

[at noodls] - Medifocus Inc. Announces Exclusive Agreement With Major Academic Medical Center to License Technology to Develop Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy COLUMBIA, Md. and Toronto, ...

Medifocus Inc. Presenting Papers at Biotechnology and Information Technology's 5th Annual Symposium in Beijing, October 20-22, 2015

10/19/2015 12:03 pm

[Marketwired] - Medifocus, Inc. , a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and Breast Cancer, today announced ...

Medifocus Inc. Announces Exclusive Agreement With Major Academic Medical Center to License Technology to Develop Heat-Activated and Tumor-Targeted Immunotherapy and Gene Therapy

10/15/2015 08:03 pm

[Marketwired] - Medifocus, Inc. , a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for the treatment of Benign Prostatic Hyperplasia and breast cancer, today announced ...

Medifocus, Inc. Presentation Now Available for On-Demand Viewing

10/6/2015 12:00 pm

[PR Newswire] - COLUMBIA, Md. and TORONTO, Oct. 6, 2015 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends to gene therapy, today announced that the October 1 presentation from Dr. Augustine Y. Cheung, PhD, President and CEO, is now available for on-demand viewing at VirtualInvestorConferences.com.

Medifocus, Inc. Presentation Now Available for On-Demand Viewing

10/6/2015 12:00 pm

[CNW Group] - Medifocus, Inc. Presentation Now Available for On-Demand Viewing

Medifocus, Inc. Announces Major Milestone of 100,000 Prolieve(R) Treatments

10/1/2015 11:01 pm

[at noodls] - Medifocus Inc. Announces Approach of Major Milestone of 100,000 Prolieve(R) Treatments COLUMBIA, Md. and Toronto, ON- September 30, 2015 - Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) (Medifocus or the ...

Medifocus, Inc. Announces Approach of Major Milestone of 100,000 Prolieve(R) Treatments

9/30/2015 03:00 pm

[Marketwired] - Medifocus, Inc. , a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends ...

Medifocus, Inc. to Present Live via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 10:45am ET

9/29/2015 12:05 pm

[PR Newswire] - COLUMBIA, Md. and TORONTO, Sept. 29, 2015 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical technologies that utilizes heat-activation to treat conditions ranging from urological problems to breast cancer treatment and extends to gene therapy, announced today that Dr. Augustine Y. Cheung, PhD, President and CEO), will present live at VirtualInvestorConferences.com on October 1, 2015. On June 16th, 2015, the Company appointed Christopher Kaplan as a member of the its recently formed Strategic Advisory Board (SAB).

Medifocus, Inc. to Present Live via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 10:45am ET

9/29/2015 12:05 pm

[CNW Group] - Medifocus, Inc. to Present Live via Webcast at VirtualInvestorConferences.com on October 1, 2015 at 10:45am ET

Medifocus Inc. Announces Units Offering

9/28/2015 09:00 pm

[CNW Group] - Medifocus Inc. Announces Units Offering

OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1

9/28/2015 01:00 pm

[PR Newswire] - NEW YORK, Sept. 28, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets for 10,000 U.S. and global securities, today announced its ...

OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1

9/28/2015 01:00 pm

[CNW Group] - OTC Markets Group to Host Virtual Investor Conference for OTCQX Life Science Companies - October 1

Medifocus, Inc. Appoints Christopher Kaplan to Its Strategic Advisory Board

6/16/2015 09:01 pm

[at noodls] - Medifocus Inc. Appoints Christopher Kaplan to Its Strategic Advisory Board COLUMBIA, Md. and Toronto, ON- June 16, 2015 - Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) (Medifocus or the Company), a medical ...